BDB553340

CD11a Rat anti-Mouse, FITC, Clone: M17/4, BD

Manufacturer: BD Biosciences

Select a Size

Pack Size SKU Availability Price
Each of 1 BDB553340-Each-of-1 In Stock ₹ 40,762.00

BDB553340 - Each of 1

₹ 40,762.00

In Stock

Quantity

1

Base Price: ₹ 40,762.00

GST (18%): ₹ 7,337.16

Total Price: ₹ 48,099.16

Antigen

CD11a

Classification

Monoclonal

Concentration

0.5mg/mL

Description

Itgal; Integrin alpha-L; Integrin αL; ITAL; LFA-1A; LFA-1α; Ly-15

Host Species

Rat

Purification Method

Affinity Purified

Regulatory Status

RUO

Target Species

Mouse

Isotype

IgG2a κ

Applications

Flow Cytometry

Clone

M17/4

Conjugate

FITC

Formulation

Aqueous buffered solution containing ≤0.09% sodium azide.

Immunogen

C57BL/6 Mouse Splenic Secondary Cytotoxic T Lymphocytes

Quantity

0.5 mg

Primary or Secondary

Primary

Content And Storage

Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.

Related Products

Img

BD Biosciences

BDB553120

--

Img

BD Biosciences

BDB553177

--

Img

BD Biosciences

BDB553801

--

Img

BD Biosciences

BDB552143

--

Img

BD Biosciences

BDB553800

--

Img

BD Biosciences

BDB553260

--

Img

BD Biosciences

BDB553802

--

Img

BD Biosciences

BDB553111

--

Description

  • The M17/4 antibody reacts with the 180 kDa αL chain of LFA-1 (CD11a/CD18, αLβ2 integrin), a heterodimeric surface glycoprotein expressed on almost all leukocytes
  • CD8a+CD8b- intestinal intraepithelial T lymphocytes, which are believed to be thymus independent, do not express CD11a
  • LFA-1 mediates a variety of heterotypic and homotypic intercellular adhesions through interaction with ICAM-1 (CD54) and ICAM-2 (CD102), including participation in the immunological synapses between CD8+ T lymphocytes and antigen-presenting cells
  • mAb M17/4 blocks a variety of LFA-1-mediated cells interactions in vitro, and costimulatory effects have also been described
  • In vivo treatment with M17/4 mAb reduces the severity of graft-versus-host reactions, prolongs allograft survival, inhibits the development of autoimmunity, and blocks substance P-induced leukocyte migration
  • The M17/4 and 2D7 (Cat
  • No
  • 553120) antibodies are reported to recognize different epitopes of the CD11a molecule.